alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
STATEMENT OF INCOME, STATEMENT OF CASH FLOWS AND BALANCE SHEET AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000762129
<NAME> CILCORP INC.
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                      854,517
<OTHER-PROPERTY-AND-INVEST>                    168,012
<TOTAL-CURRENT-ASSETS>                         148,254
<TOTAL-DEFERRED-CHARGES>                        45,841
<OTHER-ASSETS>                                 568,173
<TOTAL-ASSETS>                               1,784,797
<COMMON>                                             0
<CAPITAL-SURPLUS-PAID-IN>                      468,833
<RETAINED-EARNINGS>                              1,865
<TOTAL-COMMON-STOCKHOLDERS-EQ>                 470,698
<PREFERRED-MANDATORY>                           22,000
<PREFERRED>                                     44,120
<LONG-TERM-DEBT-NET>                           730,445
<SHORT-TERM-NOTES>                              40,000
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                  29,900
<LONG-TERM-DEBT-CURRENT-PORT>                        0
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                      1,046
<LEASES-CURRENT>                                   532
<OTHER-ITEMS-CAPITAL-AND-LIAB>                 446,056
<TOT-CAPITALIZATION-AND-LIAB>                1,784,797
<GROSS-OPERATING-REVENUE>                      171,123
<INCOME-TAX-EXPENSE>                             4,442
<OTHER-OPERATING-EXPENSES>                     142,617
<TOTAL-OPERATING-EXPENSES>                     147,059
<OPERATING-INCOME-LOSS>                         24,064
<OTHER-INCOME-NET>                               (275)
<INCOME-BEFORE-INTEREST-EXPEN>                  23,789
<TOTAL-INTEREST-EXPENSE>                        17,240
<NET-INCOME>                                     6,549
<PREFERRED-STOCK-DIVIDENDS>                        840
<EARNINGS-AVAILABLE-FOR-COMM>                    5,709
<COMMON-STOCK-DIVIDENDS>                         3,100
<TOTAL-INTEREST-ON-BONDS>                       15,668
<CASH-FLOW-OPERATIONS>                          58,911
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
#### 4.1007 Solicitation alternative line item proposal.

Solicitations should be structured to allow offerors to propose alternative line items (see 4.1008 and 52.212-1(e)). For example, when soliciting certain items using units of measure such as kit, set, or lot, the offeror may not be able to group and deliver all items in a single shipment.
#### 326.605-2 Performance and payment bonds.

Solicitations requiring performance and payment bonds must conform to FAR Part 28 and authorize use of any of the types of security acceptable in accordance with FAR Subpart 28.2 or section 11 of Public Law 98-449, the Indian Financing Act Amendments of 1984 (25 U.S.C. 47a). In accordance with FAR 28.102 and 25 U.S.C. 47a, the CO may accept alternative forms of security in lieu of performance and payment bonds if a determination is made that such forms of security provide the Government with adequate security for performance and payment.
# C_2021088EN.01000401.xml

| 15.3.2021 | EN | Official Journal of the European Union | C 88/4 |
| --- | --- | --- | --- |

15.3.2021

EN

Official Journal of the European Union

C 88/4

---

DECISION OF THE GENERAL COURT

of 10 February 2021

on judicial vacations

(2021/C 88/03)

THE GENERAL COURT

Having regard to Article 41(2) of the Rules of Procedure,

HAS ADOPTED THIS DECISION:

Article 1

For the judicial year beginning on 1 September 2021, the dates of the judicial vacations within the meaning of Article 41(2) and (6) of the Rules of Procedure are as follows:

| — | Christmas 2021: from Monday 20 December 2021 to Sunday 9 January 2022 inclusive, |
| --- | --- |

—

Christmas 2021: from Monday 20 December 2021 to Sunday 9 January 2022 inclusive,

| — | Easter 2022: from Monday 11 April 2022 to Sunday 24 April 2022 inclusive, |
| --- | --- |

—

Easter 2022: from Monday 11 April 2022 to Sunday 24 April 2022 inclusive,

| — | Summer 2022: from Saturday 16 July 2022 to Wednesday 31 August 2022 inclusive. |
| --- | --- |

—

Summer 2022: from Saturday 16 July 2022 to Wednesday 31 August 2022 inclusive.

Article 2

This decision shall enter into force on the day of its publication in the Official Journal of the European Union.

Luxembourg, 10 February 2021.

Registrar

E. COULON

President

M. VAN DER WOUDE

---
EXHIBIT 10.8

January 5, 1998



Dr. Ralph W.F. Hardy
PO Box 509
Clarence Center, NY  14032

Dear Dr. Hardy:

By this letter agreement, BioTechnica would like to amend your Consulting 
Agreement dated November 27, 1996, as follows:

2.  Term; Payment Upon Termination

(a)  The term of this Agreement shall commence on January 1, 1998, and shall 
terminate on the earlier of the death of the Consultant or on December 31, 
1998 (the "Expiration Date").

If the provisions of this letter are in accordance with your understanding, 
please sign and return one of the enclosed copies.

Very truly yours,



/s/ Bruno Carette
President 



/s/ Ralph W.F. Hardy                      January 5, 1998
Ralph W.F. Hardy                          Date
# FY 2017 NCC

V1 9.6.2018		

# Sheet2

# Sheet3
Exhibit
10.(b)


 


CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM


 


We
hereby consent to the incorporation by reference in this Registration Statement
on Form N-4  (File Nos. 333-153041 and
811-8108) of our report dated March 30, 2009 relating to the financial
statements, financial statement schedules and the effectiveness of internal
control over financial reporting, which appears in Protective Life Insurance
Company’s Annual Report on Form 10-K for the year ended December 31,
2008 and is included in Post-Effective Amendment No. 2 to the Registration
Statement on Form N-4 (File Nos. 333-153041 and 811-8108).  We also consent to the incorporation by
reference in this Registration Statement on Form N-4 of our report dated April 24,
2009, relating to the financial statements of The Protective Variable Annuity
Separate Account, which is included in Post-Effective Amendment No. 2 to
the Registration Statement on Form N-4 (File Nos. 333-153041 and 811-8108).


 


 





PricewaterhouseCoopers
LLP 


Birmingham,
AL


October 28,
2009
#### 42.1103 Policy.

The contractor is responsible for timely contract performance. The Government will maintain surveillance of contractor performance as necessary to protect its interests. When the contracting office retains a contract for administration, the contracting officer administering the contract shall determine the extent of surveillance.
The Honorable Fratis L. Duff 

Director 

Texas Department of Health 

Resources 

1100 West 49th Street 

Austin, Texas 78756 

Opinion No. H949 

Re: Rule-making power 

of Director of Health 

Resources. 

Dear Dr. Duff: 

You have requested our opinion concerning the effect 

of House Bill 2164 of the 64th Legislature upon the general 

rule-making powers of the Department of Health Resources. 

You have not presented any specific rule or regulation for 

our review. 

Prior to 1975, article 4418d, V.T.C.S., provided that 

the State Health Officer would be the "executive head" of 

the State Department of Health and that he could promulgate 

"administrative rules and regulations" for the effective 

performance of his duties. House Bill 2164 amended article 

4418d to provide for a Director of Health Resources in the 

place of the State Health Officer. In so doing, 

regarding rules and regulations was deleted. 

the language 

Acts 1975, 

64th Leg., ch. 323, 832 at 847. 

House Bill 2164 also amended article 4418a. V.T.C.S., 

to provide: 

The Texas Board of Health Resources shall: 

. . . . 

(3) adopt rules, not inconsistent 

with law, for its own procedure . . . . 

Id. 

P. 3967 
The Honorable Fratis L. Duff - page 2 (H-949) 

The Board of Health Resources is a creation of the 

Leaislature: as such it has "onlv such powers as are delesated 

to>it, expressly and impliedly, by the Legislature." State 

v. Jackson, 376 S.W.2d 341, 344 (Tex. 1964); Stauffer v. 

m of San Antonio, 344 S.W.2d 158 (Tex. 1961). Attorney 

Genera Opinion M-610 (1970). See Attorney General Opinion - 

H-475 (1974). 

Since the general rule-making power contained in article 

4418d was deleted and since this general power is not 

elsewhere provided, in our opinion the Director of Health 

Resources has no general rule-making power. Of course, 

the Board of Health Resources has the power to issue procedural rules under article 4418a, but this power does not 

extend to substantive rules. See Kee v. Baber, 303 S.W.2d 

376 (Tex. 1957). However, thislack of general rule-making 

power does not affect the specific grants of rule-making 

power contained in other statutes, e.g. articles 4476-7, -8, 

-11, -13, -15, 4477-6, 4477-7, V.T.C.S. See V.T.C.S. art. 

44189. In addition, some rules may be valid as impliedly 

authorized to effectuate a power expressly granted by statute. 

See Terre11 v. Sparks, 135 S.W. 519 (Tex. 1911). - - 

SUMMARY 

The Department of Health Resources has 

no general rule-making power. Whether a 

rule is valid under some specific statutory 

authorization or is impliedly authorized to 

effectuate an expressly granted power would 

depend upon the particular rule involved. 

ery truly yours, Al. J ,&T&> 

/ 

/'Attorney General of Texas 

," 

/,.~~,--+E?PROVED : 

c. ROBERT HEATH, Chairman 

Opinion Committee 

jwb 

P. 3968
**Exhibit 31.1****Certifications**I, Timothy R. Eller, certify that:1. I have reviewed this report on Form 10-Q of Centex Corporation;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures [as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)] andinternal control over financial reporting [as defined in Exchange Act Rules 13a-15(f) and15d-15(f)] for the registrant and have:(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;(b) Designed such internal control over financial reporting, or caused such internal control overfinancial reporting to be designed under our supervision, to provide reasonable assurance regardingthe reliability of financial reporting and the preparation of financial statements for externalpurposes in accordance with generally accepted accounting principles;(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and(d) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing the equivalent functions):(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal controls over financial reporting.Date:November 1, 2005
# C_2017341EN.01000301.xml

| 12.10.2017 | EN | Official Journal of the European Union | C 341/3 |
| --- | --- | --- | --- |

12.10.2017

EN

Official Journal of the European Union

C 341/3

---

Euro exchange rates (1)

1

11 October 2017

(2017/C 341/04)

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1830 |
| JPY | Japanese yen | 132,72 |
| DKK | Danish krone | 7,4430 |
| GBP | Pound sterling | 0,89710 |
| SEK | Swedish krona | 9,5313 |
| CHF | Swiss franc | 1,1524 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 9,3790 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,879 |
| HUF | Hungarian forint | 309,93 |
| PLN | Polish zloty | 4,2851 |
| RON | Romanian leu | 4,5865 |
| TRY | Turkish lira | 4,3337 |
| AUD | Australian dollar | 1,5186 |
| CAD | Canadian dollar | 1,4798 |
| HKD | Hong Kong dollar | 9,2344 |
| NZD | New Zealand dollar | 1,6723 |
| SGD | Singapore dollar | 1,6044 |
| KRW | South Korean won | 1 339,10 |
| ZAR | South African rand | 16,0525 |
| CNY | Chinese yuan renminbi | 7,7989 |
| HRK | Croatian kuna | 7,5115 |
| IDR | Indonesian rupiah | 15 997,95 |
| MYR | Malaysian ringgit | 4,9911 |
| PHP | Philippine peso | 60,863 |
| RUB | Russian rouble | 68,4492 |
| THB | Thai baht | 39,258 |
| BRL | Brazilian real | 3,7515 |
| MXN | Mexican peso | 22,2167 |
| INR | Indian rupee | 77,0660 |

Currency

Exchange rate

USD

US dollar

1,1830

JPY

Japanese yen

132,72

DKK

Danish krone

7,4430

GBP

Pound sterling

0,89710

SEK

Swedish krona

9,5313

CHF

Swiss franc

1,1524

ISK

Iceland króna

NOK

Norwegian krone

9,3790

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,879

HUF

Hungarian forint

309,93

PLN

Polish zloty

4,2851

RON

Romanian leu

4,5865

TRY

Turkish lira

4,3337

AUD

Australian dollar

1,5186

CAD

Canadian dollar

1,4798

HKD

Hong Kong dollar

9,2344

NZD

New Zealand dollar

1,6723

SGD

Singapore dollar

1,6044

KRW

South Korean won

1 339,10

ZAR

South African rand

16,0525

CNY

Chinese yuan renminbi

7,7989

HRK

Croatian kuna

7,5115

IDR

Indonesian rupiah

15 997,95

MYR

Malaysian ringgit

4,9911

PHP

Philippine peso

60,863

RUB

Russian rouble

68,4492

THB

Thai baht

39,258

BRL

Brazilian real

3,7515

MXN

Mexican peso

22,2167

INR

Indian rupee

77,0660

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                             DEC-31-1996
<PERIOD-END>                                  DEC-31-1996 
<CASH>                                            16,547
<INT-BEARING-DEPOSITS>                             1,397
<FED-FUNDS-SOLD>                                       0
<TRADING-ASSETS>                                   4,622
<INVESTMENTS-HELD-FOR-SALE>                            0              
<INVESTMENTS-CARRYING>                           145,050
<INVESTMENTS-MARKET>                             145,446
<LOANS>                                          250,011
<ALLOWANCE>                                        2,798
<TOTAL-ASSETS>                                   432,518
<DEPOSITS>                                       343,256
<SHORT-TERM>                                      13,217  
<LIABILITIES-OTHER>                                3,306
<LONG-TERM>                                       25,000
<COMMON>                                          14,440
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<OTHER-SE>                                        33,299
<TOTAL-LIABILITIES-AND-EQUITY>                   432,518  
<INTEREST-LOAN>                                   22,544
<INTEREST-INVEST>                                  7,991
<INTEREST-OTHER>                                      58
<INTEREST-TOTAL>                                  30,593
<INTEREST-DEPOSIT>                                12,185   
<INTEREST-EXPENSE>                                12,687
<INTEREST-INCOME-NET>                             17,906
<LOAN-LOSSES>                                      1,042
<SECURITIES-GAINS>                                   284
<EXPENSE-OTHER>                                   12,017
<INCOME-PRETAX>                                    7,601
<INCOME-PRE-EXTRAORDINARY>                         5,632
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                       5,632
<EPS-PRIMARY>                                       1.96
<EPS-DILUTED>                                       1.94
<YIELD-ACTUAL>                                      8.21
<LOANS-NON>                                        2,910
<LOANS-PAST>                                         767
<LOANS-TROUBLED>                                       0 
<LOANS-PROBLEM>                                        0
<ALLOWANCE-OPEN>                                   2,574
<CHARGE-OFFS>                                      1,296
<RECOVERIES>                                         478    
<ALLOWANCE-CLOSE>                                  2,798
<ALLOWANCE-DOMESTIC>                               2,798
<ALLOWANCE-FOREIGN>                                    0
<ALLOWANCE-UNALLOCATED>                                0
        

</TABLE>
Case: 1:12-cr-00545 Document #: 10 Filed: 08/01/12 Page 1 of 1 PageID #:14
#### 37.200 Scope of subpart.

This subpart prescribes policies and procedures for acquiring advisory and assistance services by contract. The subpart applies to contracts, whether made with individuals or organizations, that involve either personal or nonpersonal services.
Second Department,

April, 1962

(April 2, 1962)

#### Rose Abramson et al., Appellants, v. Vernon Manor Cooperative Apartments, Section II Incorporated, Respondent.

Motion by respondent to dismiss appeal granted; appeal dismissed. Beldock, P. J., Ughetta, Kleinfeld, Brennan and Hill, JJ., concur.
#### In the Matter of the Claim of Walter Kuehnhold, Respondent, v. Yardney Electric Corp. et al., Appellants. Workmen’s Compensation Board, Respondent.

Hamm, J.

Appeal from a board decision that the claimant sustained a 20% causally related loss of vision of the left eye as found by the Referee. The claimant testified that, while at work in early January of 1962, acid splashed in his eyes and that on subsequent occasions of work his eyes were exposed to fumes. The board’s examining physician found a loss of vision of 29%. The claimant’s first physician, a general practitioner who saw him only twice, made no examination as to extent of loss of vision. An ophthalmologist, who treated the claimant from April 4 through April 18, 1962, was called by the carrier and testified that none of the claimant’s impaired vision was due to the injury for. which he treated him. An impartial specialist found “no loss of vision that can be blamed on this accident”. The carrier’s eye specialist agreed with the impartial specialist. The claimant testified that he wore glasses approximately five or six years before the accident. He was asked this question and made this answer: “ Q. With those glasses were you able to see everything clearly and comfortably? A. Everything. I did everything, welding and wiring. I have to see that and after. that I can’t see no more — nothing, making wiring or nothing.” Dr. Gaynin, an ophthalmologist who treated the claimant from May 16, 1962, to January 4, 1963, testified that the claimant suffered from bilateral subacute conjunctivitis and that this acute condition was caused by the injury. He further testified that the claimant had a loss of vision in the left eye of 22%% and that “acid irritation going directly into the eyes, plus use of fumes” could cause such a condition. The board was not bound to follow the views of its impartial medical. specialist *(Matter of Schillaci*v. *175 West 12th St. Constr. Corp.,*21 A D 2d 934) and in the exercise of its fact-finding power the board could properly accept the testimony of one expert and reject that of other experts despite their numerical superiority *(Matter of Nowicki*v. *Allegheny Ludlum Steel Corp.,*21 A D 2d 946). While the medical evidence of Dr. Gaynin might have contained greater certainty, we cannot say that his testimony, when viewed in the light of the record as.a whole, did not satisfy the requirement of *Matter of Ernest*v. *Boggs Lake Estates*(12 N Y 2d 414) *(Matter of Campanini*v. *Colorado Fuel & Iron Corp.,*21 A D 2d 927, mot. for lv. to app. den. 14 N Y 2d 487). The weight and credibility of medical proof are for the board’s evaluation *(Matter of Copeland*v. *Cucci Constr. Co.,*19 A D 2d 666) and we cannot say that the evidence which it chose to accept was not substantial. Decision affirmed, with costs to the Workmen’s Compensation Board. Gibson, P. J., Reynolds, Taylor and Aulisi, JJ., concur.
IV 

118TH CONGRESS 

1ST SESSION H. CON. RES. 70 

Expressing support for designation of the first Friday of October as 

‘‘Manufacturing Day’’. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 29, 2023 

Mrs. TORRES of California (for herself, Mr. FLEISCHMANN, and Mr. 

GROTHMAN) submitted the following concurrent resolution; which was referred to the Committee on Oversight and Accountability 

CONCURRENT RESOLUTION 

Expressing support for designation of the first Friday of 

October as ‘‘Manufacturing Day’’. 

Whereas, according to the most recent data, manufacturers 

contributed $2,790,000,000,000 to the economy, accounting for 11 percent of gross domestic product; 

Whereas this figure has risen significantly over the past decade, from $1,930,000,000,000 in 2012; 

Whereas manufacturers in the United States are a significant 

driver of innovation, spending $347,700,000,000 on research and development in 2020; 

Whereas nearly 13,000,000 people in the United States (or 

over 8 percent of the workforce) are employed directly in 

manufacturing, while many millions more jobs are supported through the supply chain and related industries; 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HCON 70 IH 

Whereas the number of skilled, family wage jobs in this sector is increasing, presenting the opportunity to promote 

the benefits of a career in manufacturing to young people 

and their parents; and 

Whereas the first Friday of October would be an appropriate 

date to designate as ‘‘Manufacturing Day’’: Now, therefore, be it 

1 Resolved by the House of Representatives (the Senate 

2 concurring), That Congress supports the designation of 

3 ‘‘Manufacturing Day’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB